ZCR 2060

Drug Profile

ZCR 2060

Latest Information Update: 06 Jul 2001

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Zeria
  • Class Anti-inflammatories; Antiallergics; Antiasthmatics; Antihistamines; Benzoic acids
  • Mechanism of Action Histamine H1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Allergic rhinitis; Asthma; Dermatitis

Most Recent Events

  • 06 Jul 2001 Discontinued-Preclinical for Allergic rhinitis in Japan (Unknown route)
  • 06 Jul 2001 Discontinued-Preclinical for Asthma in Japan (Unknown route)
  • 06 Jul 2001 Discontinued-Preclinical for Dermatitis in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top